531
Views
56
CrossRef citations to date
0
Altmetric
Original

Retinopathy of Prematurity: Current Concepts in Molecular Pathogenesis

, &
Pages 77-81 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohsen Gohari, Seyed Alireza Dastgheib, Mahmood Noorishadkam, Mohamad Hosein Lookzadeh, Seyed Reza Mirjalili, Mohammad Javad Akbarian-Bafghi, Majid Morovati-Sharifabad & Hossein Neamatzadeh. (2020) Association of eNOS and ACE Polymorphisms with Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. Fetal and Pediatric Pathology 39:4, pages 334-345.
Read now

Articles from other publishers (55)

Po-Yi Wu, Yuan-Kai Fu, Rey-In Lien, Ming-Chou Chiang, Chien-Chung Lee, Hung-Chi Chen, Yi-Jen Hsueh, Kuan-Jen Chen, Nan-Kai Wang, Laura Liu, Yen-Po Chen, Yih-Shiou Hwang, Chi-Chun Lai & Wei-Chi Wu. (2023) Systemic Cytokines in Retinopathy of Prematurity. Journal of Personalized Medicine 13:2, pages 291.
Crossref
Seyed Ahmad Rasoulinejad & Pegah Kiyamehr. (2023) The Determinative Role of Cytokines in Retinopathy of Prematurity. Current Molecular Medicine 23:1, pages 36-43.
Crossref
M. Margarita Parra, Melissa Chandler & M. Elizabeth Hartnett. 2023. Pediatric Vitreoretinal Surgery. Pediatric Vitreoretinal Surgery 203 220 .
Khaled El-Atawi, Nayef Alansar, Mahmoud ElHalik, Amani Abdelsamed & Rim Mahfouz. (2022) Management of retinopathy of prematurity: an updated review. Journal of Pediatrics & Neonatal Care 12:1, pages 24-29.
Crossref
Sibel Guzel, Charles L. Cai, Jacob V. Aranda & Kay D. Beharry. (2021) Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia. Pharmaceuticals 14:10, pages 967.
Crossref
Ronald H. Silverman, Raksha Urs, Danny H.-Kauffmann Jokl, Leora Pinto, Osode Coki, Rakesh Sahni, Jason D. Horowitz & Steven E. Brooks. (2021) Ocular Blood Flow in Preterm Neonates: A Preliminary Report. Translational Vision Science & Technology 10:2, pages 22.
Crossref
Hyun-Su Ri, Sun Sik Bae, Jung Min Ha, Hee Young Kim & Seung-Hoon Baek. (2020) The effect of desflurane on retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Journal of Anesthesia 34:3, pages 352-357.
Crossref
Talkad S. Raghuveer & R. Zackula. (2020) Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis. NeoReviews 21:4, pages e249-e263.
Crossref
Cüneyt TAYMAN, Ufuk ÇAKIR & Özdemir ÖZDEMİR. (2019) The value of VEGF and IGF-1 in the diagnosis retinopathy of prematurity and follow-up of response to laser therapyPrematür retinopatisinin tanısı ve lazer tedavisine cevabın takibinde VEGF ve IGF-1’in değeri. Cukurova Medical Journal 44:3, pages 745-752.
Crossref
Feng Pan. (2019) Defocused Image Changes Signaling of Ganglion Cells in the Mouse Retina. Cells 8:7, pages 640.
Crossref
Wenqin Xu, Ying Wu, Zhicha Hu, Lijuan Sun, Guorui Dou, Zifeng Zhang, Haiyang Wang, Changmei Guo & Yusheng Wang. (2019) Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity. Molecular Therapy - Nucleic Acids 16, pages 778-790.
Crossref
Ufuk Cakir, Cuneyt Tayman, Cigdem Yucel & Ozdemir Ozdemir. (2019) Can IL-33 and Endocan be New Markers for Retinopathy of Prematurity?. Combinatorial Chemistry & High Throughput Screening 22:1, pages 41-48.
Crossref
Peter J Belin, Andrew C Lee, Giovanni Greaves, Jennifer Kosoy & Ronni M Lieberman. (2019) The use of bevacizumab in pediatric retinal and choroidal disease: A review. European Journal of Ophthalmology 29:3, pages 338-347.
Crossref
Kay Beharry, Charles Cai, Faisal Siddiqui, Sara Chowdhury, Christina D’Agrosa, Gloria Valencia & Jacob Aranda. (2018) Comparative Effects of Coenzyme Q10 or n-3 Polyunsaturated Fatty Acid Supplementation on Retinal Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy. Antioxidants 7:11, pages 160.
Crossref
Michael W. Gaynon, Ronald J. Wong, David K. Stevenson & Philip Sunshine. (2018) Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors. Journal of Perinatology 38:10, pages 1295-1300.
Crossref
Ryan Swan, Sang Jin Kim, J. Peter Campbell, R.V. Paul Chan, Kemal Sonmez, Kent D. Taylor, Xiaohui Li, Yii-Der Ida Chen, Jerome I. Rotter, Charles Simmons & Michael F. Chiang. (2018) The Genetics of Retinopathy of Prematurity: A Model for Neovascular Retinal Disease. Ophthalmology Retina 2:9, pages 949-962.
Crossref
Tadashi YokoiSatoshi Katagiri, Miina HiraokaYuri NakayamaKatsuhiro HosonoYoshihiro HottaSachiko NishinaNoriyuki Azuma. (2018) ATYPICAL FORM OF RETINOPATHY OF PREMATURITY WITH SEVERE FIBROVASCULAR PROLIFERATION IN THE OPTIC DISK REGION. Retina 38:8, pages 1605-1612.
Crossref
Vanessa R. Kay, Chandrakant Tayade, Peter Carmeliet & B. Anne Croy. (2017) Influences of placental growth factor on mouse retinal vascular development. Developmental Dynamics 246:9, pages 700-712.
Crossref
Medha Sharma & Deborah K. VanderVeen. (2017) Identification and Treatment of Retinopathy of Prematurity: Update 2017. NeoReviews 18:2, pages e84-e90.
Crossref
Efrén González, Andreas Stahl, Ann Hellström & Lois E.H. Smith. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology 1681 1686.e2 .
Minjian Zhao, Zhaoshi Yu, Zhihong Li, Jun Tang, Xu Lai & Liming Liu. (2016) Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism. Oncology Reports.
Crossref
Naomi H. Fink, Carmel T. Collins, Robert A. Gibson, Maria Makrides & Irmeli A. Penttila. (2016) Targeting inflammation in the preterm infant: The role of the omega-3 fatty acid docosahexaenoic acid. Journal of Nutrition & Intermediary Metabolism 5, pages 55-60.
Crossref
A M de Lucas Cerrillo, W S Bond & T S Rex. (2015) Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin. Gene Therapy 22:5, pages 365-373.
Crossref
Xiaoming Gong & Lewis P. Rubin. (2015) Role of macular xanthophylls in prevention of common neovascular retinopathies: Retinopathy of prematurity and diabetic retinopathy. Archives of Biochemistry and Biophysics 572, pages 40-48.
Crossref
Min Zhang, Sanjun Chu, Fanxing Zeng & Haifeng Xu. (2015) Bevacizumab modulates the process of fibrosis in vitro . Clinical & Experimental Ophthalmology 43:2, pages 173-179.
Crossref
W S Harris & M L Baack. (2014) Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity. Journal of Perinatology 35:1, pages 1-7.
Crossref
Andreas Gschlie?er, Eva Stifter, Thomas Neumayer, Elisabeth Moser, Andrea Papp, Guido Dorner & Ursula Schmidt-Erfurth. (2014) Twin?twin transfusion syndrome as a possible risk factor for the development of retinopathy of prematurity. Graefe's Archive for Clinical and Experimental Ophthalmology 253:1, pages 151-156.
Crossref
Atsuro Uchida, Masayuki Miwa, Hajime Shinoda, Takashi Koto, Norihiro Nagai, Hiroshi Mochimaru, Yohei Tomita, Mariko Sasaki, Kazushige Ikeda, Kazuo Tsubota & Yoko Ozawa. (2014) Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks. Journal of Ophthalmology 2014, pages 1-5.
Crossref
Ann Hellström, Lois EH Smith & Olaf Dammann. (2013) Retinopathy of prematurity. The Lancet 382:9902, pages 1445-1457.
Crossref
György Balla & Miklós Szabó. (2013) Chronic morbidities of premature newborns. Orvosi Hetilap 154:38, pages 1498-1511.
Crossref
Thomas A. Mendel, Erin B. D. Clabough, David S. Kao, Tatiana N. Demidova-Rice, Jennifer T. Durham, Brendan C. Zotter, Scott A. Seaman, Stephen M. Cronk, Elizabeth P. Rakoczy, Adam J. Katz, Ira M. Herman, Shayn M. Peirce & Paul A. Yates. (2013) Pericytes Derived from Adipose-Derived Stem Cells Protect against Retinal Vasculopathy. PLoS ONE 8:5, pages e65691.
Crossref
Deborah K. VanderVeen, Camilia R. Martin, Reshma Mehendale, Elizabeth N. Allred, Olaf Dammann & Alan Leviton. (2013) Early Nutrition and Weight Gain in Preterm Newborns and the Risk of Retinopathy of Prematurity. PLoS ONE 8:5, pages e64325.
Crossref
Frank Ong, Jane Kuo, Wei-Chi Wu, Ching-Yu Cheng, Wendell-Lamar Blackwell, Brian Taylor, Wayne Grody, Jerome Rotter, Chi-Chun Lai & Tien Wong. (2013) Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. Journal of Personalized Medicine 3:1, pages 40-69.
Crossref
Samuel K. Houston, Charles C. Wykoff, Audina M. Berrocal, Ditte J. Hess & Timothy G. Murray. (2011) Laser treatment for retinopathy of prematurity. Lasers in Medical Science 28:2, pages 683-692.
Crossref
Wei-Chi Wu, Hsi-Kung Kuo, Po-Ting Yeh, Chung-May Yang, Chi-Chun Lai & San-Ni Chen. (2013) An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan. American Journal of Ophthalmology 155:1, pages 150-158.e1.
Crossref
Graham E Quinn & Alistair R Fielder. 2013. Pediatric Ophthalmology and Strabismus. Pediatric Ophthalmology and Strabismus 432 448.e8 .
Amanda Villalvilla, Manuel Moro, Luis Arruza, Santiago Redondo, Arturo Fernández-Cruz & Raquel Fernández-Durango. (2012) Circulating endothelial progenitor cells are reduced in rat oxygen-induced retinopathy despite a retinal SDF-1/CXCR4 and VEGF proangiogenic response. Life Sciences 91:7-8, pages 264-270.
Crossref
Yagna P. R. Jarajapu, Jun Cai, Yuanqing Yan, Sergio Li Calzi, Jennifer L. Kielczewski, Ping Hu, Lynn C. Shaw, Sue M. Firth, Tailoi Chan-Ling, Michael E. Boulton, Robert C. Baxter & Maria B. Grant. (2012) Protection of Blood Retinal Barrier and Systemic Vasculature by Insulin-Like Growth Factor Binding Protein-3. PLoS ONE 7:7, pages e39398.
Crossref
Wenlin Li & Deyong Jiang. (2012) Effect of Resveratrol on Bcl-2 and VEGF Expression in Oxygen-Induced Retinopathy of Prematurity. Journal of Pediatric Ophthalmology & Strabismus 49:4, pages 230-235.
Crossref
Massimo Dal Monte, Valentina Latina, Elena Cupisti & Paola Bagnoli. (2012) Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn-Schmiedeberg's Archives of Pharmacology 385:5, pages 481-494.
Crossref
Jamil A. Matthews, Frédéric G. Sala, Allison L. Speer, Ying Li, David Warburton & Tracy C. Grikscheit. (2012) Mesenchymal-Specific Inhibition of Vascular Endothelial Growth Factor (VEGF) Attenuates Growth in Neonatal Mice. Journal of Surgical Research 172:1, pages 40-47.
Crossref
Alejandra G. de Alba Campomanes, Gil Binenbaum & Graham E. Quinn. 2012. Avery's Diseases of the Newborn. Avery's Diseases of the Newborn 1423 1440 .
Rosemary D. Higgins. 2012. Textbook of Clinical Pediatrics. Textbook of Clinical Pediatrics 391 394 .
Timothy S. Kern. 2012. Visual Dysfunction in Diabetes. Visual Dysfunction in Diabetes 143 155 .
Li-Juan Duan, Kotaro Takeda & Guo-Hua Fong. (2011) Prolyl Hydroxylase Domain Protein 2 (PHD2) Mediates Oxygen-Induced Retinopathy in Neonatal Mice. The American Journal of Pathology 178:4, pages 1881-1890.
Crossref
Wei-Chi Wu, Po-Ting Yeh, San-Ni Chen, Chung-May Yang, Chi-Chun Lai & Hsi-Kung Kuo. (2011) Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan. Ophthalmology 118:1, pages 176-183.
Crossref
J. Figueras Aloy. (2010) Eritropoyetina en neonatología. Anales de Pediatría 73:6, pages 301-304.
Crossref
J. Figueras-Aloy, E. Álvarez-Domínguez, M. Morales-Ballus, M.D. Salvia-Roiges & G. Moretones-Suñol. (2010) Administración precoz de eritropoyetina en el prematuro extremo, ¿factor de riesgo de la retinopatía del prematuro?. Anales de Pediatría 73:6, pages 327-333.
Crossref
Dong Hyun Jo, Jin Hyoung Kim & Jeong Hun Kim. (2010) How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness. Archives of Pharmacal Research 33:10, pages 1557-1565.
Crossref
Andrew Scott, Michael B. Powner, Pranita Gandhi, Claire Clarkin, David H. Gutmann, Randall S. Johnson, Napoleone Ferrara & Marcus Fruttiger. (2010) Astrocyte-Derived Vascular Endothelial Growth Factor Stabilizes Vessels in the Developing Retinal Vasculature. PLoS ONE 5:7, pages e11863.
Crossref
S. Rey & G. L. Semenza. (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovascular Research 86:2, pages 236-242.
Crossref
Ricardo J. GiordanoMarina Cardó-VilaAhmad SalamehCristiane D. AnobomBenjamin D. ZeitlinDavid H. Hawke, Ana P. ValenteFábio C. L. AlmeidaJacques E. NörRichard L. Sidman, Renata PasqualiniWadih Arap. (2010) From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway. Proceedings of the National Academy of Sciences 107:11, pages 5112-5117.
Crossref
Woo Taek KimEok Soo Suh. (2010) Retinal Protective Effects of Resveratrol via Modulation of Nitric Oxide Synthase on Oxygen-induced Retinopathy. Korean Journal of Ophthalmology 24:2, pages 108.
Crossref
M. A. Abdelsaid, B. A. Pillai, S. Matragoon, R. Prakash, M. Al-Shabrawey & A. B. El-Remessy. (2009) Early Intervention of Tyrosine Nitration Prevents Vaso-Obliteration and Neovascularization in Ischemic Retinopathy. Journal of Pharmacology and Experimental Therapeutics 332:1, pages 125-134.
Crossref
Jacob M. Jones, Trevor McFarland & J. Timothy Stout. 2011. Therapeutic Angiogenesis for Vascular Diseases. Therapeutic Angiogenesis for Vascular Diseases 67 80 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.